Literature DB >> 28812143

Serotonin in psychiatry: in vitro disease modeling using patient-derived neurons.

Krishna C Vadodaria1, Shani Stern1, Maria C Marchetto1, Fred H Gage2.   

Abstract

Several lines of evidence implicate serotonin in the etiology of multiple psychiatric disorders, especially mood disorders, such as major depressive disorder (MDD) and bipolar disorder (BD). Much of our current understanding of biological mechanisms underlying serotonergic alterations in mood disorders comes from animal studies. Innovation in induced pluripotent stem cell and transdifferentiation technologies for deriving neurons from adult humans has enabled the study of disease-relevant cellular phenotypes in vitro. In this context, human serotonergic neurons can now be generated using three recently published methodologies. In this mini-review, we broadly discuss evidence linking altered serotonergic neurotransmission in MDD and BD and focus on recently published methods for generating human serotonergic neurons in vitro.

Entities:  

Keywords:  5-HT; Bipolar; Depression; Human serotonergic neurons; Induced pluripotent stem cells; Mood disorders; Transdifferentiation; iSN

Mesh:

Substances:

Year:  2017        PMID: 28812143     DOI: 10.1007/s00441-017-2670-4

Source DB:  PubMed          Journal:  Cell Tissue Res        ISSN: 0302-766X            Impact factor:   5.249


  10 in total

1.  Mitochondria, Metabolism, and Redox Mechanisms in Psychiatric Disorders.

Authors:  Yeni Kim; Krishna C Vadodaria; Zsolt Lenkei; Tadafumi Kato; Fred H Gage; Maria C Marchetto; Renata Santos
Journal:  Antioxid Redox Signal       Date:  2019-02-01       Impact factor: 8.401

2.  Evaluation of Neurotransmitter Alterations in Four Distinct Brain Regions After Rapid Eye Movement Sleep Deprivation (REMSD) Induced Mania-Like Behaviour in Swiss Albino Mice.

Authors:  Saiful Alom Siddique; Thangavel Tamilselvan; Manikkannan Vishnupriya; Elumalai Balamurugan
Journal:  Neurochem Res       Date:  2018-04-18       Impact factor: 3.996

3.  Robust derivation of transplantable dopamine neurons from human pluripotent stem cells by timed retinoic acid delivery.

Authors:  José M Dias; Andrew F Adler; Mariya Kozhevnikova; Zhanna Alekseenko; Josina Anna van Lunteren; Sara Nolbrant; Ashwini Jeggari; Svitlana Vasylovska; Takashi Yoshitake; Jan Kehr; Marie Carlén; Andrey Alexeyenko; Malin Parmar; Johan Ericson
Journal:  Nat Commun       Date:  2022-06-01       Impact factor: 17.694

4.  Neural stem cells: developmental mechanisms and disease modeling.

Authors:  Xinyu Zhao; Darcie L Moore
Journal:  Cell Tissue Res       Date:  2018-01       Impact factor: 5.249

Review 5.  Genetics of Alcohol Use Disorder: A Role for Induced Pluripotent Stem Cells?

Authors:  Iya Prytkova; Alison Goate; Ronald P Hart; Paul A Slesinger
Journal:  Alcohol Clin Exp Res       Date:  2018-07-05       Impact factor: 3.455

6.  Sensing serotonin secreted from human serotonergic neurons using aptamer-modified nanopipettes.

Authors:  Fred H Gage; Krishna C Vadodaria; Nako Nakatsuka; Kelly J Heard; Alix Faillétaz; Dmitry Momotenko; János Vörös
Journal:  Mol Psychiatry       Date:  2021-03-25       Impact factor: 15.992

7.  Serotonin Neuronal Function from the Bed to the Bench: Is This Really a Mirrored Way?

Authors:  Adeline Etievant; Thorsten Lau; Guillaume Lucas; Nasser Haddjeri
Journal:  eNeuro       Date:  2019-06-05

8.  Serotonergic Modulation of Persistent Inward Currents in Serotonergic Neurons of Medulla in ePet-EYFP Mice.

Authors:  Yi Cheng; Nan Song; Renkai Ge; Yue Dai
Journal:  Front Neural Circuits       Date:  2021-04-06       Impact factor: 3.492

9.  Activation of AMPA Receptors in the Lateral Habenula Produces Anxiolytic Effects in a Rat Model of Parkinson's Disease.

Authors:  Jin Zhang; Xiaobing Wang; Rick E Bernardi; Jun Ju; Shoupeng Wei; Zhiting Gong
Journal:  Front Pharmacol       Date:  2022-01-25       Impact factor: 5.810

Review 10.  Novel test strategies for in vitro seizure liability assessment.

Authors:  Anke M Tukker; Remco H S Westerink
Journal:  Expert Opin Drug Metab Toxicol       Date:  2021-02-17       Impact factor: 4.481

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.